| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
|
J Clin Oncol
|
2003
|
12.48
|
|
2
|
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
|
J Clin Oncol
|
2002
|
9.83
|
|
3
|
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.
|
J Clin Oncol
|
2003
|
9.72
|
|
4
|
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.
|
J Clin Oncol
|
2006
|
3.50
|
|
5
|
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy.
|
Cancer
|
2003
|
2.06
|
|
6
|
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study.
|
J Clin Oncol
|
2002
|
1.80
|
|
7
|
A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
|
Cancer Res
|
2004
|
1.67
|
|
8
|
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.
|
J Clin Oncol
|
2003
|
1.54
|
|
9
|
Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
|
Clin Cancer Res
|
2003
|
1.47
|
|
10
|
Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
|
J Biol Chem
|
2002
|
1.42
|
|
11
|
Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
|
Mol Pharmacol
|
2002
|
1.16
|
|
12
|
Increasing evidence for a human breast carcinoma virus with geographic differences.
|
Cancer
|
2004
|
1.10
|
|
13
|
Effect of ON 01910.Na, an anticancer mitotic inhibitor, on cell-cycle progression correlates with RanGAP1 hyperphosphorylation.
|
Cancer Res
|
2011
|
1.08
|
|
14
|
Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
|
Biochem Biophys Res Commun
|
2002
|
1.05
|
|
15
|
Characterization of viral particles isolated from primary cultures of human breast cancer cells.
|
Cancer Res
|
2007
|
1.04
|
|
16
|
Detection of human mammary tumor virus proteins in human breast cancer cells.
|
J Virol Methods
|
2009
|
1.02
|
|
17
|
Human mammary tumor virus in inflammatory breast cancer.
|
Cancer
|
2010
|
0.98
|
|
18
|
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
|
J Clin Oncol
|
2003
|
0.95
|
|
19
|
Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells.
|
Oncol Rep
|
2007
|
0.94
|
|
20
|
A concise history of the cancer and leukemia group B.
|
Clin Cancer Res
|
2006
|
0.94
|
|
21
|
[Detection of murine mammary tumor virus (MMTV) env gene-like sequences in breast cancer from Argentine patients].
|
Medicina (B Aires)
|
2002
|
0.86
|
|
22
|
Downstaging cancer in rural Africa.
|
Int J Cancer
|
2014
|
0.85
|
|
23
|
Human mammary tumor virus (HMTV) in endometrial carcinoma.
|
Int J Gynecol Cancer
|
2013
|
0.84
|
|
24
|
Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.
|
Cancer Res
|
2002
|
0.83
|
|
25
|
Transcription profiles of non-immortalized breast cancer cell lines.
|
BMC Cancer
|
2006
|
0.82
|
|
26
|
Transcription profile of a human breast cancer cell line expressing MMTV-like sequences.
|
Infect Agent Cancer
|
2006
|
0.80
|
|
27
|
Presence of MMTV-like env gene sequences in human breast cancer.
|
Breast Cancer Res Treat
|
2010
|
0.79
|
|
28
|
Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice.
|
Genes Cancer
|
2011
|
0.79
|
|
29
|
Comment on the review by Joshi and Buehring.
|
Breast Cancer Res Treat
|
2012
|
0.78
|
|
30
|
Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand.
|
Biochem Pharmacol
|
2003
|
0.77
|
|
31
|
Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer.
|
Am J Cancer Res
|
2013
|
0.76
|
|
32
|
A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells.
|
Proc Natl Acad Sci U S A
|
2004
|
0.76
|
|
33
|
Contribution by Faedo et al. (Clin cancer res 2004;10:4417-4419).
|
Clin Cancer Res
|
2005
|
0.75
|
|
34
|
Transformation of NIH 3T3 cells by enhanced PAR expression.
|
Biochem Biophys Res Commun
|
2004
|
0.75
|
|
35
|
Haemangioblastic transformation of myeloproliferative disease?
|
Br J Haematol
|
2007
|
0.75
|
|
36
|
The Classic: amputation and adriamycin in primary osteosarcoma. 1974.
|
Clin Orthop Relat Res
|
2005
|
0.75
|
|
37
|
Discontinuous drug binding to proteins: binding of an antineoplastic benzyl styryl sulfone to albumin and enzymes in vitro and in phase I clinical trials.
|
Drug Metab Dispos
|
2010
|
0.75
|
|
38
|
PAR, a protein involved in the cell cycle, is functionally related to chromosomal passenger proteins.
|
Int J Oncol
|
2011
|
0.75
|